GXGerresheimer GXI.DE · XETRA
32.08 € -1.60% (-0.52 €)
- Market cap
- 1.11B €
- Enterprise value
- 2.53B €
- P/E
- -
- Forward P/E
- 15.6x
- PEG
- -
- P/S
- 0.5x
- P/FCF
- -
- EV/EBITDA
- 8.1x
- ROIC
- -7.0%
- Gross margin
- 18.3%
- Net margin
- -13.8%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 4.6x
- Beta
- 0.45
- Free float
- 92.8%
About the company
Gerresheimer AG (GXI) is a German multinational company specializing in the production and supply of specialty glass and plastics primarily for the pharmaceutical industry. With a broad range of products, such as injection vials, ampoules, and pharmacy containers, Gerresheimer AG is a key player in the pharmaceutical supply chain. The company is known for its innovative technology and high-quality standards, making it a preferred partner for pharmaceutical companies worldwide. Gerresheimer AG (GXI) could be an attractive investment opportunity for investors seeking stability and growth potential in the pharmaceutical supply sector.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Uwe Ferdinand Röhrhoff
Employees
13,301
Headquarters
Düsseldorf
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Revenue grew by 11% a year over the last 3 years.
- What speaks for it: Analysts expect revenue to grow by 14% this fiscal year.
- What to watch: It missed profit estimates 6 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What to watch: Repaying its net debt would take 4.6 years of operating profit.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number